We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 21-40 of 10,000 results
  1. Targeting CD73 limits tumor progression and enhances anti-tumor activity of anti-PD-1 therapy in intrahepatic cholangiocarcinoma

    Background & aims

    Patients with intrahepatic cholangiocarcinoma (iCCA) respond poorly to immune checkpoint blockades (ICBs). In this study, we aimed...

    Bao-Ye Sun, Dai Zhang, ... Shuang-Jian Qiu in Journal of Cancer Research and Clinical Oncology
    Article Open access 13 July 2024
  2. Re-administration of platinum-based chemotherapy for recurrent endometrial cancer: an ancillary analysis of the SGSG-012/GOTIC-004/Intergroup study

    Background

    We previously demonstrated the applicability of the concept of “platinum sensitivity” in recurrent endometrial cancer. Although immune...

    Shoji Nagao, Shin Nishio, ... Hisashi Masuyama in International Journal of Clinical Oncology
    Article Open access 13 July 2024
  3. An international delphi survey and consensus meeting to define the risk factors for ureteral stricture after endoscopic treatment for urolithiasis

    Purpose

    Iatrogenic ureteral strictures (US) after endoscopic treatment for urolithiasis represent a significant healthcare concern. However,...

    Stefano Moretto, A. Saita, ... N.M. Buffi in World Journal of Urology
    Article 13 July 2024
  4. Ferroptosis – a potential feature underlying neratinib-induced colonic epithelial injury

    Purpose

    Neratinib, a small-molecule tyrosine kinase inhibitor (TKI) that irreversibly binds to human epidermal growth factor receptors 1, 2 and 4...

    Triet P. M. Nguyen, Susan L. Woods, ... Joanne M. Bowen in Cancer Chemotherapy and Pharmacology
    Article Open access 13 July 2024
  5. Changes in skeletal muscle function during chemotherapy and related factors in patients with acute leukemia

    Introduction

    Skeletal muscle function is an important prognostically relevant indicator in patients with acute leukemia (AL), but skeletal dysfunction...

    Yusuke Terao, Yasuhide Nakayama, ... Minoru Yamada in Supportive Care in Cancer
    Article 13 July 2024
  6. LncRNA ZFAS1 regulates ATIC transcription and promotes the proliferation and migration of hepatocellular carcinoma through the PI3K/AKT signaling pathway

    Purpose

    Long noncoding RNAs (lncRNAs) exert a significant influence on various cancer-related processes through their intricate interactions with...

    Baoyang Luo, Lin Zhuang, ... Haisheng Fang in Journal of Cancer Research and Clinical Oncology
    Article Open access 13 July 2024
  7. Low dose of dexamethasone combined with netupitant and palonosetron in preventing nausea and vomiting in breast cancer patients induced by anthracycline drugs

    Background

    To study the effects of various courses of dexamethasone (DEX) combined with 5-HT3 receptor antagonists (RA) and NK-1 RA in suppressing...

    Yehuan Liu, Peipei Hu, ... Suxia Li in Clinical and Translational Oncology
    Article 13 July 2024
  8. Elemental Diet as a Therapeutic Modality: A Comprehensive Review

    Elemental diets have been employed for the management of various diseases for over 50 years, with several mechanisms mediating their beneficial...

    Jason Nasser, Sepideh Mehravar, ... Ali Rezaie in Digestive Diseases and Sciences
    Article Open access 13 July 2024
  9. Dose prescription for stereotactic body radiotherapy: general and organ-specific consensus statement from the DEGRO/DGMP Working Group Stereotactic Radiotherapy and Radiosurgery

    Purpose and objective

    To develop expert consensus statements on multiparametric dose prescriptions for stereotactic body radiotherapy (SBRT) aligning...

    Thomas B. Brunner, Judit Boda-Heggemann, ... Oliver Blanck in Strahlentherapie und Onkologie
    Article Open access 12 July 2024
  10. Recent Advances of Neoadjuvant Immunotherapy for Urothelial Bladder Cancer

    Urothelial bladder cancer is one of the most common malignant tumors of the urinary system, which accounts for 90~95% of urothelial carcinoma....

    Mengjie Zhang, Jian Wu, ... Haojie Shang in Annals of Surgical Oncology
    Article 12 July 2024
  11. Hepatocellular Carcinoma in Asia: Physician and Patient Perspectives on Surveillance, Diagnosis, and Treatment

    Purpose

    In several Asian countries, hepatocellular carcinoma (HCC) is a leading cause of cancer deaths. HCC risk factors in Asia differ from those...

    Rosmawati Mohamed, Wendy Wang, ... Chee-Kiat Tan in Journal of Gastrointestinal Cancer
    Article Open access 12 July 2024
  12. Outcomes of deep venous thrombosis management and associated factors among patients in tertiary hospitals in Addis Ababa, Ethiopia: a multicenter retrospective cohort study

    Background

    Pulmonary embolism (PE) and deep venous thrombosis (DVT) are the two most important manifestations of venous thromboembolism (VTE). DVT...

    Seble Birhane, Melak Gedamu Beyene, ... Assefa Mulu Baye in Thrombosis Journal
    Article Open access 12 July 2024
  13. Clinical characteristics and prognosis of pancreatitis associated with immune checkpoint inhibitors

    Background and objective

    Immune checkpoint inhibitors (ICIs) have shown remarkable efficacy against various cancers in clinical practice. However,...

    Junzi Zhang, **anzhuo Jiang, ... Junjie Hou in Clinical and Translational Oncology
    Article 12 July 2024
  14. Clip** the Positive Lymph Node in Patients with Clinically Node Positive Breast Cancer Treated with Neoadjuvant Chemotherapy: Impact on Axillary Surgery in the ISPY-2 Clinical Trial

    Background

    For patients with clinically node-positive (cN+) breast cancer undergoing neoadjuvant chemotherapy (NAC), retrieving previously clipped,...

    Kayla M. Switalla, Judy C. Boughey, ... Rita A. Mukhtar in Annals of Surgical Oncology
    Article Open access 12 July 2024
  15. Synergistic induction of mitotic pyroptosis and tumor remission by inhibiting proteasome and WEE family kinases

    Mitotic catastrophe (MC), which occurs under dysregulated mitosis, represents a fascinating tactic to specifically eradicate tumor cells. Whether...

    Zhan-Li Chen, Chen **e, ... Shi-Mei Zhuang in Signal Transduction and Targeted Therapy
    Article Open access 12 July 2024
  16. Patient attitudes and experiences towards exercise during oncological treatment. A qualitative systematic review

    Purpose

    Exercise and physical activity (PA) during oncological treatment have many benefits. However, PA levels and adherence are often low. This...

    Alice Finch, Alex Benham in Supportive Care in Cancer
    Article Open access 12 July 2024
  17. Effect of dipeptidyl peptidase-4 inhibitors on tumor necrosis factor alpha levels in patients with type 2 diabetes mellitus

    Aims

    Dipeptidyl peptidase-4 inhibitors (DPP-4i) served as oral antidiabetic agents for treatment of type 2 diabetes mellitus (T2DM). Although an...

    Lijia Zhao, Jie Meng, ... **n Liu in European Journal of Medical Research
    Article Open access 12 July 2024
  18. A DPC Database Study on the Safety of Atezolizumab/Carboplatin/Etoposide in Extensive-Disease Small Cell Lung Cancer in Japanese Patients

    Introduction

    Atezolizumab, carboplatin, and etoposide (ACE) therapy is a standard of care for extensive-disease small cell lung cancer (SCLC);...

    Motohiro Tamiya, Shunichiro Iwasawa, ... Yasutaka Chiba in Advances in Therapy
    Article Open access 12 July 2024
Did you find what you were looking for? Share feedback.